Company research
TFA Therapeutics, Inc.
CIK 1885680Updated Sep 24, 2026
SecurityRAJAF · OTC · equity
Name history
Cordyceps Sunshine Biotech Holdings Co., Ltd. · through Jun 25, 2026
RAJAF price & chart
Loading TradingView…
OTC:RAJAF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 4,657,511Source | 4,623,704Source | 3,351,782Source | 2,104,853Source |
| Property, Plant and Equipment, NetUSD | 3,632,901Source | 3,909,599Source | 2,814,766Source | 1,425,135Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,199Source | 37,284Source | 23,104Source | 16,100Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 305Source | — | 149,510Source |
| Inventory, NetUSD | 674,196Source | — | — | 313,530Source |
| Assets, CurrentUSD | 997,742Source | 601,602Source | 327,175Source | 501,552Source |
| Operating Lease, Right-of-Use AssetUSD | 13,097Source | 99,328Source | 195,775Source | — |
| Other Assets, NoncurrentUSD | 13,771Source | 13,175Source | 14,066Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,192,062Source | 4,999,247Source | 3,503,578Source | 3,056,187Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 11,112Source | 11,112Source | 11,112Source | 11,112Source |
| Additional Paid in CapitalUSD | 221,288Source | 221,288Source | 221,288Source | 221,288Source |
| Retained Earnings (Accumulated Deficit)USD | -854,046Source | -699,224Source | -472,966Source | -1,224,575Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 87,095Source | 91,281Source | 88,770Source | 40,841Source |
| Stockholders' Equity Attributable to ParentUSD | -534,551Source | -375,543Source | -151,796Source | -951,334Source |
| Liabilities and EquityUSD | 4,657,511Source | 4,623,704Source | 3,351,782Source | 2,104,853Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,192,062Source | 4,986,645Source | 2,966,143Source | 2,935,130Source |
| Operating Lease, Liability, CurrentUSD | 13,173Source | 87,016Source | 90,091Source | 57,109Source |
| Accounts Payable, CurrentUSD | 365,140Source | 276,125Source | 185,434Source | 751,135Source |
| Operating Lease, Liability, NoncurrentUSD | — | 12,602Source | 106,356Source | 121,057Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 85,074Source | 32,410Source | 26,889Source | 62,754Source |
| Long-term Debt, Current MaturitiesUSD | — | — | — | 57,109Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 431,079Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | 56,757Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | -185,797Source |
| Increase (Decrease) in InventoriesUSD | 358,549Source | — | 192,634Source | -48,833Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | 182,849Source | -122,450Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | -42,221Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -35,845Source | 312,006Source | 359,724Source | -321,378Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | -305,637Source | -319,820Source | -475Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 349,237Source | 319,487Source | 475Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | -32,208Source | 245,787Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -34,085Source | 14,180Source | 7,004Source | -83,584Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,199Source | 37,284Source | 23,104Source | 16,100Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 2,185Source | 150Source | — | — |
| Income Taxes Paid, NetUSD | — | — | — | 792Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,760Source | 7,811Source | -692Source | -7,518Source |
| Additional Financial Items | ||||
| AmortizationUSD | 74,017Source | 16,793Source | — | — |
| Amortization of Debt Issuance CostsUSD | — | — | 86,216Source | — |
| DepreciationUSD | 135,243Source | 407,265Source | 56,757Source | 24,760Source |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of TaxUSD | — | — | 865,085Source | — |
| Gain (Loss) on Disposition of AssetsUSD | — | 4,328Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | 2,437,980Source | — |
| General and Administrative ExpenseUSD | — | — | 538,554Source | 572,589Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 1,177Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -154,822Source | -226,258Source | 169,285Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 582,324Source | — |
| Income Tax Expense (Benefit)USD | — | 34,957Source | 21,530Source | 792Source |
| Inventory Write-downUSD | — | — | — | 84,709Source |
| Net Income (Loss) Attributable to ParentUSD | -154,822Source | -226,258Source | 751,609Source | -720,093Source |
| Nonoperating Income (Expense)USD | -13,694Source | -7,388Source | 37,018Source | -76,599Source |
| Operating ExpensesUSD | 901,869Source | 717,673Source | 538,554Source | 576,030Source |
| Operating Lease, ExpenseUSD | 91,310Source | 90,609Source | 81,203Source | — |
| Other Nonoperating Income (Expense)USD | 5,485Source | 5,339Source | -37,018Source | -4,855Source |
| Realized Investment Gains (Losses)USD | — | — | 865,085Source | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,245,348Source | 1,253,484Source | 882,533Source | 448,785Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -141,128Source | -183,913Source | 227,833Source | -642,702Source |
| Other Nonoperating Income (Expense)USD | 5,485Source | 5,339Source | -37,018Source | -4,855Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -154,822Source | -191,301Source | 190,815Source | — |
| Income Tax Expense (Benefit)USD | — | 34,957Source | 21,530Source | 792Source |
| Net Income (Loss) Attributable to ParentUSD | -154,822Source | -226,258Source | 751,609Source | -720,093Source |
| Earnings Per Share, BasicUSD per share | 0Source | 0Source | 0.01Source | -0.01Source |
| Earnings Per Share, DilutedUSD per share | 0Source | 0Source | 0.01Source | -0.01Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 111,120,000Source | 111,120,000Source | 111,120,000Source | 104,417,534Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 111,120,000Source | 111,120,000Source | 111,120,000Source | 104,417,534Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | — | 34,957Source | 21,530Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | 168,899Source |
| General and Administrative ExpenseUSD | — | — | 538,554Source | 572,589Source |
| Gross ProfitUSD | 760,741Source | 533,760Source | 766,387Source | -66,672Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -154,822Source | -226,258Source | 169,285Source | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 0Source | 0Source | 0Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 0Source | 0Source | 0Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 582,324Source | — |
| Interest ExpenseUSD | — | — | 26,535Source | 71,772Source |
| Interest Income (Expense), Nonoperating, NetUSD | -19,179Source | -17,055Source | -39,770Source | — |
| Interest Income, OtherUSD | — | — | 7Source | 28Source |
| Labor and Related ExpenseUSD | — | — | 109,295Source | 110,938Source |
| Nonoperating Income (Expense)USD | -13,694Source | -7,388Source | 37,018Source | -76,599Source |
| Operating ExpensesUSD | 901,869Source | 717,673Source | 538,554Source | 576,030Source |
| Operating Lease, ExpenseUSD | 91,310Source | 90,609Source | 81,203Source | — |
| Other ExpensesUSD | — | — | — | 35,690Source |
| Other General and Administrative ExpenseUSD | 901,869Source | 717,673Source | 193,569Source | — |
| Other IncomeUSD | — | — | 2,752Source | — |
| Realized Investment Gains (Losses)USD | — | — | 865,085Source | — |
| Research and Development ExpenseUSD | — | — | — | 118,444Source |
| Selling ExpenseUSD | — | — | — | 3,441Source |